BWI: Ecron Acunova CRO Expands its Clinical Research Centre for Drug Development

Press release from Business Wire India
Source: Ecron Acunova
Monday, January 17, 2011 06:00 PM IST (12:30 PM GMT)
Editors: General: Consumer interest; Business: Advertising, PR & marketing, Business services, Education & training, Healthcare, biotechnology & pharmaceutical; Healthcare
--------------------------------------------------
Ecron Acunova CRO Expands its Clinical Research Centre for Drug Development
80 bed drug research centre opens at Ecron Acunova CRO in Mangalore

Bangalore, Karnataka, India, Monday, January 17, 2011 -- (Business Wire India) -- Ecron Acunova, a leading CRO with extensive operation in India and Europe announced expansion of their Mangalore Clinical Pharmacology Unit to a 80 bed facility. The Research Centre was dedicated by Dr. Ramdas M Pai, Chancellor, Manipal University. This expansion caters to the growing needs of its global clients in Pharmaco-Kinetic and Pharmaco Dynamic studies. This takes total bed capacity to 176 units in research centres at Mangalore, Manipal and Bangalore. Drug research involves analysing the activity of the drug in plasma using spectroscopy. Highly sophisticated spectrometers have been added. Speaking on the occasion Dr. Ramdas Pai said: 'I commend the safe conduct of studies for Indian and global companies, leveraging the scientific and clinical talent of India. It is heartening to note that studies conducted at the centre, got US FDA approval, leading to launch of drugs for treatment of HIV, cancer etc.'

Mr. D A Prasanna, Chairman and Managing Director said, 'In a short period of five years, over 250 Phase one studies and over 70 late phase studies have been conducted taking the company to top 3 position amongst nearly 100 CRO's in India. Ecron Acunova offers solutions according to our clients' needs without compromising quality. This capacity expansion will help us to serve our clients at a faster pace."

About Ecron Acunova:

Ecron Acunova (EA) - is a global CRO headquartered in Bangalore with offices across India. European headquarters at Frankfurt, oversees operations in 14 European countries. Ecron Acunova provides end-to-end services for Phase I - IV clinical research, including Clinical Operations, Data Management, Biostatistics, PK/PD services and Central Lab. Ecron Acunova provides clinical development services to the pharmaceutical, biotechnology, nutritional, device and medical diagnostics industries. The service quality, therapeutic expertise and global reach have allowed Ecron Acunova to grow rapidly, building a list of demanding clients. Ecron Acunova provides a package of services coupled with the ability to rapidly conduct clinical trials utilizing a world class delivery platform. Team of 350 professionals includes 69 MDs and PhDs. As a full service CRO, Ecron Acunova is reputed to accelerate pharma time-to-market cost effectively.

About Manipal Group:

Manipal Education and Medical Group (MEMG) International India Pvt., Ltd. (www.manipal.edu) operates educational and healthcare institutions in India and internationally. It offers education and healthcare, continued medical education, and distance education services. The company specializes in research of genomics, genetics, and stem cells. Manipal Education and Medical Group was founded in 1953 and is based in Bangalore, India


CONTACT DETAILS
Dr Klaus D. Wiedey, Ecron Acunova, +49 69 66 80 30-0, klaus.wiedey@ecronacunova.com
DA Prasanna, Ecron Acunova, +91 (80) 66915701, da.prasanna@ecronacunova.com
Dr. Kohkan Shamsi, Ecron Acunova, +1 973 396 2742, kohkan.shamsi@ecronacunova.com

KEYWORDS
CONSUMER, MARKETING, BUSINESS SERVICES, EDUCATION, HEALTHCARE, HEALTHCARE

If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.

Submit your press release at http://www.businesswireindia.com